HomeClinical TopicsFDA approves new drug for thrombocytopenia in patients with chronic liver disease

FDA approves new drug for thrombocytopenia in patients with chronic liver disease

Author(s):

On May 21, the U.S. Food and Drug Administration (FDA) approved approved Doptelet (avatrombopag) tablets to treat thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure.

Read more via FDA.gov.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content